Kurmann, Christoph C.
Mujanovic, Adnan
Piechowiak, Eike I.
Dobrocky, Tomas
Zibold, Felix
Beyeler, Morin
Vynckier, Jan
Seiffge, David
Meinel, Thomas R.
Mordasini, Pasquale
Arnold, Marcel
Fischer, Urs
Gralla, Jan
Kaesmacher, Johannes http://orcid.org/0000-0002-9177-2289
Funding for this research was provided by:
Schweizerische Akademie der Medizinischen Wissenschaften
Article History
Received: 22 September 2021
Accepted: 10 December 2021
First Online: 6 January 2022
Declarations
:
: T.R. Meinel reports research support from the Bangerter Rhyner Foundation, Swiss National Foundation and the Swiss Heart Foundation. M. Arnold reports personal fees from Bayer, Bristol-Myers Squibb, Medtronic, Amgen, Daiichi Sankyo, Nestlé Health Sciences, Boehringer Ingelheim, and Covidien during the conduct of the study. U. Fischer reports grants during the conduct of the study from Medtronic, Stryker, and CSL Behring outside the submitted work. J. Gralla is a global principal investigator of STAR (Solitaire FR Thrombectomy for Acute Revascularisation), Clinical Event Committee member of the PROMISE study (Prospective, Multicenter, Observational, Single-Arm European Registry on the ACE Reperfusion Catheters and the Penumbra System in the Treatment of Acute Ischemic Stroke; Penumbra), and a principal investigator and consultant for the SWIFT DIRECT study (Solitaire With the Intention for Thrombectomy Plus Intravenous tPA Versus DIRECT Solitaire Stent-Retriever Thrombectomy in Acute Anterior Circulation Stroke; Medtronic) and receives Swiss National Science Foundation grants for magnetic resonance imaging in stroke. J. Kaesmacher reports grants from the Swiss Academy of Medical Sciences/Bangerter Foundation, Swiss Stroke Society, and Clinical Trial Unit Bern during the conduct of the study. C.C. Kurmann, A. Mujanovic, E.I. Piechowiak, T. Dobrocky, F. Zibold, M. Beyeler, J. Vynckier, D. Seiffge and P. Mordasini declare that they have no competing interests.
: This study was performed in line with the principles of the Declaration of Helsinki. Institutional Review Board approval was obtained. Consent to participate: written informed consent was obtained from all subjects (patients) in this study. Consent for publication: not applicable.